Relative equilibrium plot improves graphical analysis and allows bias correction of standardized uptake value ratio in quantitative 11C-PiB PET studies

Journal of Nuclear Medicine

Volumn 53, Issue 4, 2012, Pages 622-628

  Zhou, Yun ^a   Sojkova, Jitka ^a,b   Resnick, Susan M ^b   Wong, Dean F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

11C PiB; Bias; PET; RE plot; SUVR

Indexed keywords

PITTSBURGH COMPOUND B;

ARTICLE; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; HUMAN; IMAGE ANALYSIS; ISOTOPE ANALYSIS; MILD COGNITIVE IMPAIRMENT; OPTICAL RESOLUTION; PARIETAL CORTEX; PLOTS AND CURVES; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RELATIVE EQUILIBRIUM BASED GRAPHICAL PLOT METHOD; STANDARDIZATION; STANDARDIZED UPTAKE VALUE RATIO; SYSTEMATIC ERROR; TEMPORAL CORTEX; THEORETICAL STUDY;

AGED; AGED, 80 AND OVER; BENZOTHIAZOLES; BIAS (EPIDEMIOLOGY); BIOLOGICAL TRANSPORT; COMPUTER GRAPHICS; HUMANS; KINETICS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 84859409233     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.095927     Document Type: Article

References (39)

1. Vallabhajosula S. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid. Semin Nucl Med. 2011;41:283-299.
2. Ziolko SK, Weissfeld LA, Klunk WE, et al. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. Neuroimage. 2006;33:94-102. (Pubitemid 44397577)
3. 11C]PIB uptake is increased in mild cognitive impairment. Neurology. 2007;68:1603-1606.
4. 11C]PIB uptake in Alzheimer disease. Neurology. 2006;67:1575-1580.
5. Aizenstein HJ, Nebes RD, Saxton JA, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008;65:1509-1517.
6. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-1539. (Pubitemid 47301451)
7. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab. 1991;11:735-744.
8. 11C-methyl]-(2)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740-747.
9. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153-158.
10. 11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. Neuroimage. 2007;36:298-312.
11. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840. (Pubitemid 26292051)
12. Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab. 2005;25:1528-1547. (Pubitemid 41541962)
13. Lopresti BJ, Klunk WE, Mathis CA, et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med. 2005;46:1959-1972. (Pubitemid 46657441)
14. 11C]PIB studies. Neuroimage. 2008;42:76-86.
15. McNamee RL, Yee SH, Price JC, et al. Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements. J Nucl Med. 2009;50:348-355.
16. 18F] cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab. 1993;13:24-42.
17. Logan J, Alexoff D, Kriplani A. Simplifications in analyzing positron emission tomography data: effects on outcome measures. Nucl Med Biol. 2007;34:743-756. (Pubitemid 47505400)
18. 18F]SPA-RQ and positron emission tomography: a procedure for assessing errors from image reconstruction and physiological modeling. Mol Imaging Biol. 2007;9:284-294.
19. Slifstein M, Laruelle M. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J Nucl Med. 2000;41:2083-2088. (Pubitemid 32038700)
20. Logan J, Fowler JS, Volkow ND, Ding YS, Wang GJ, Alexoff DL. A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab. 2001;21:307-320. (Pubitemid 32207430)
21. 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. J Nucl Med. 2006;47:43-50.
22. 11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab. 2000;20:225-243.
23. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23:1096-1112.
24. Zhou Y, Endres CJ, Brasic JR, Huang SC, Wong DF. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. Neuroimage. 2003;18:975-989. (Pubitemid 36513470)
25. Zhou Y, Ye W, Brasic JR, Crabb AH, Hilton J, Wong DF. A consistent and efficient graphical analysis method to improve the quantification of reversible tracer binding in radioligand receptor dynamic PET studies. Neuroimage. 2009;44:661-670.
26. Resnick SM, Goldszal AF, Davatzikos C, et al. One-year age changes in MRI brain volumes in older adults. Cereb Cortex. 2000;10:464-472. (Pubitemid 30318453)
27. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397-405. (Pubitemid 32217456)
28. Driscoll I, Resnick SM, Troncoso JC, An Y, O'Brien R, Zonderman AB. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol. 2006;60:688-695. (Pubitemid 46048486)
29. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 2000;54:2072-2077. (Pubitemid 30397204)
30. Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab. 1993;13:15-23. (Pubitemid 23016599)
31. Lawson C, Hanson RJ. Solving Least Squares Problem. Englewood Cliffs, NJ: Prentice Hall; 1974
32. Zhou Y, Ye W, Brasic JR, et al. Spectral analysis with a minimal basis function approach for quantification of ligand-receptor dynamic PET study. J Cereb Blood Flow Metab. 2005;25:S634.
33. Akaike H. An information criteria (AIC). Math Sci. 1976;14:5-9.
34. Turkheimer FE, Hinz R, Cunningham VJ. On the undecidability among kinetic models: from model selection to model averaging. J Cereb Blood Flow Metab. 2003;23:490-498. (Pubitemid 36403031)
35. Carson RE. PET physiological measurements using constant infusion. Nucl Med Biol. 2000;27:657-660.
36. Slifstein M. Revisiting an old issue: the discrepancy between tissue ratio-derived binding parameters and kinetic modeling-derived parameters after a bolus of the serotonin transporter radioligand 123I-ADAM. J Nucl Med. 2008;49:176-178. (Pubitemid 351225653)
37. 18F] FDDNP PET studies. IEEE Nucl Sci Symposium Conf Rec. 2009:3946-3949.
38. 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008;7:129-135.
39. 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med. 2010;51:913-920.